iBio Acquisitions
iBio has acquired 1 company and its latest acquisition was RubrYc Therapeutics, Inc. on Sep 2022
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
RubrYc Therapeutics, Inc.
Sep 2022
Source »$1M
RubrYc is a California-based biotechnology firm that offers solutions such as AI-powered drug discovery and antibody development for the life sciences industry.